EUVIMEDEUVIMED entdecken
Open Access

Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies

Kimberly L Fiock, Ryan K Betters, Marco M Hefti iD

Journal of Histochemistry & Cytochemistry · 2023

DOI: 10.1369/00221554231158428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Histochemistry & Cytochemistry, 2023. Verfasst von Kimberly L Fiock und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Iowa, Iowa City, Iowa. Hauptthemen laut MEDLINE: Alzheimer Disease, Pick Disease of the Brain, Supranuclear Palsy, Progressive, Tauopathies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tau phosphorylation, aggregation, and toxicity are the main drivers of neurodegeneration in multiple tauopathies, including Alzheimer’s disease (AD) and frontotemporal lobar degeneration with tau. Although aggregation and amyloid formation are often assumed to be synonymous, the ability of tau aggregates in different diseases to form amyloids in vivo has not been systematically studied. We used the amyloid dye Thioflavin S to look at tau aggregates in mixed tauopathies such as AD and primary age-related tauopathy, as well as pure 3R or 4R tauopathies such as Pick’s disease, progressive supranuclear palsy, and corticobasal degeneration. We found that aggregates of tau protein only form thioflavin-positive amyloids in mixed (3R/4R), but not pure (3R or 4R), tauopathies. Interestingly, neither astrocytic nor neuronal tau pathology was thioflavin-positive in pure tauopathies. As most current positron emission tomography tracers are based on thioflavin derivatives, this suggests that they may be more useful for differential diagnosis than the identification of a general tauopathy. Our findings also suggest that thioflavin staining may have utility as an alternative to traditional antibody staining for distinguishing between tau aggregates in patients with multiple pathologies and that the mechanisms for tau toxicity may differ between different tauopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePick Disease of the BrainSupranuclear Palsy, ProgressiveTauopathiesHumansBrainNeuronstau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseFTLDamyloidtautauopathythioflavin

Substanzen

MAPT protein, humantau Proteins

Autor:innen und Institutionen

  • Department of Pathology, University of Iowa, Iowa City, Iowa.
  • Experimental Pathology Graduate Program, University of Iowa, Iowa City, Iowa.
  • Iowa Neuroscience Institute, Iowa City, Iowa.
  • Interdisciplinary Neuroscience Graduate Program, University of Iowa, Iowa City, Iowa.

ORCID-Profile: Marco M Hefti

Förderung

  • NINDS NIH HHS

Zitieren

APA

Fiock, K. L., Betters, R. K., & Hefti, M. M. (2023). Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies. Journal of Histochemistry & Cytochemistry. https://doi.org/10.1369/00221554231158428

Vancouver

Fiock KL, Betters RK, Hefti MM. Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies. Journal of Histochemistry & Cytochemistry. 2023. doi:10.1369/00221554231158428

BibTeX
@article{Fiock2023,
  author = {Fiock, Kimberly L and Betters, Ryan K and Hefti, Marco M},
  title = {Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies},
  journal = {Journal of Histochemistry & Cytochemistry},
  year = {2023},
  doi = {10.1369/00221554231158428}
}
Kostenlos starten →